-
MS Research Supports Long-Term Targeting of Spinal Cord Demyelination
28 Mar 2024 00:30 GMT
… even in later stages of MS.
Research presented at ACTRIMS Forum 2024 …
-
Juvisé Pharmaceuticals Acquires Multiple Sclerosis Drug PONVORY® (ex-US/Canada) and Opens Its Capital to Bpifrance and Pemberton
26 Mar 2024 14:28 GMT
The French pharmaceutical company, Juvisé Pharmaceuticals, announces the acquisition of global commercial rights (excluding the United States and Canada) to Ponvory® (ponesimod) from Actelion Pharmaceuticals Ltd., a Johnson & Johnson Company (Johnson …
-
MS Awareness Month: Pharmacists Have an Integral Role in Patient Care, Support
29 Mar 2024 00:44 GMT
… a pivotal role in MS treatment by providing patient education, … outcomes.
Future Directions in MS Treatment: There is optimism for … the future of MS treatment, particularly in progressive … pharmacies that are dispensing MS treatments to our members. Since …
-
InnoCare Releases 2023 Results and Business Highlights
28 Mar 2024 16:01 GMT
… ’s potential as a leading MS treatment.
NMOSD: The Phase II clinical …
-
Houston Hosts New MS Study
28 Mar 2024 10:00 GMT
… this study will advance MS research and may expand MS treatment options. There is …
-
Are new treatments for multiple sclerosis on the horizon?
27 Mar 2024 18:35 GMT
… changer in the multiple sclerosis treatment landscape. We … B cells. In multiple sclerosis research, although they seem … inhibitors’ promise in multiple sclerosis treatment
However, Biogen is … care to revolutionize multiple sclerosis treatment?
Aside from BTK …
-
Multiple Sclerosis Market Size in the 7MM was ~USD 25 Billion in 2022, estimated DelveInsight
27 Mar 2024 11:32 GMT
… The major Multiple Sclerosis drug market is … ImStem Biotechnology)
Multiple Sclerosis Treatment Landscape
Multiple Sclerosis treatment has two aspects … more about Multiple Sclerosis Drugs in development … Overview
6. Multiple Sclerosis Treatment
7. …
-
Multiple sclerosis has distinct subtypes, study finds, pointing to different treatments
27 Mar 2024 19:21 GMT
… and confirm how well different MS treatments work for patients with these …
-
Multiple Sclerosis Awareness Month: Latest research, treatments from ACTRIMS 2024
27 Mar 2024 17:35 GMT
… to accelerated disability progression in MS
Treatment with clemastine fumarate was linked … teriflunomide for relapsing forms of MS
Treatment with evobrutinib was nonsuperior to …
-
How MSC Therapy Slows Down the Progression of Multiple Sclerosis?
26 Mar 2024 21:44 GMT
… (MSCs) is a multiple sclerosis treatment with lots of potential. … therapy is a multiple sclerosis treatment that can drastically … Therapy vs. Conventional MS Treatments
When choosing a therapy … therapy compare with traditional MS treatments?
The Advantages of …